Walgreens Boots Alliance, Inc. (WBA) is an American holding company headquartered in Deerfield, Illinois that owns Walgreens, Boots and a number of pharmaceutical manufacturing, wholesale and distribution companies. The company was formed on December 31, 2014 after Walgreens purchased the 55% stake in Switzerland-basedAlliance Boots that it did not already own. Walgreens had previously purchased 45% of the company in 2012 with an option to purchase the remaining shares within three years. Under the terms of the merger, the new company was organized into three divisions: Retail Pharmacy USA (Walgreens), Retail Pharmacy International (Boots), and Pharmaceutical Wholesale, incorporating Alliance Healthcare. The new holding company began trading on the NASDAQ on December 31, 2014. The combined business has operations in over 25 countries. Walgreens had formerly operated solely within the United States and its territories, while Alliance Boots operated a more international business. In October 2015, Walgreens Boots Alliance published its fourth quarter earnings report. Net sales in fiscal year 2015 increased by 35.4% to $103.4 billion, and net earnings rose to $4.2 billion.
Walgreens Boots Alliance Inc (WBA) Stock Drops Despite Earnings Beat WBA beat EPS estimates by 3 cents Walgreens Boots Alliance Inc (WBA) stock was down following its fiscal Q2 2016 earnings report. Walgreens reported earnings per share of $1.31 for the quarter. This is an 11% increase over EPS from the same time last year. It also beat out analysts’ estimates for the company by 3 cents. Walgreens’ revenue for the second quarter of 2016 was $30.2 billion, which matches up with what it reported during the second quarter of 2015. Wall Street was expecting revenue of $30.7 billion for the quarter. Walgreens is currently expecting EPS to be between $4.35 and $4.55 for fiscal 2016. Analysts are expecting the company to report EPS of $4.48 during this fiscal year. WBA stock was down 4% as of Tuesday morning.
Reported before open today (7/6/16) Earnings: EPS $1.18 Revenue $29.5B Estimates: EPS $1.14 Revenue $29.71B Down 2.36% today
Analyst Upgrade/Downgrade Update Brokerage firm: Jefferies Change: Upgrade Previous Rating: Hold Current Rating: Buy Previous Price Target: N/A Current Price Target: N/A
Walgreens Boots Alliance $WBA Q4 Adj Profit Tops View, But Sales Miss; down a smidge 0.2% to 77.00 in light PreM
Upcoming dividend information: Ex-Div-Date: 11/15/16 Payment Date: 12/12/16 Dividend: $0.38 Current Price: $80.35 Annual Yield: 1.87%
Drugstore chain Walgreens Boots Alliance ($WBA) may come under pressure after reporting second quarter earnings that matched estimates but on weaker than expected sales.
There was selling pressure over the past week due to news regarding Amazon possibly entering into the pharma space, but notice it was on average volume. Longs are not selling. These were traders and recent buyers selling on the news. It is currently a triple bottom play with massive support @ 80.00. Technicals are telling me a breakout above the 88.00 level is imminent with that resistance level being tested sometime around the end of June. See how the 20-day SMA consistently bounces off of the 200-day. In order for that pattern to be maintained the trend reversal must take place now since the SMA is delayed and the bounce off of it will occur while the breakout is happening. In looking at the stochastics, they have begun to uptick from their oversold conditions, further confirming a trend reversal to occur now. Three days into the week and the weekly candle is currently a doji with a slightly longer upper wick. This doji is supportive of the trend reversal but I would like to see the bottom wick get a bit longer while closing out around current levels. I am expecting WBA to test below 80.00 Thur. or Fri. but to not close below it. If WBA closes below 80.00 Thur. or Fri. my sentiments will change dramatically. We should finish out the week right around the current price of 80.50. I am expecting the buyers to jump in Tuesday after the 3-day weekend as they will most likely be doing so for the markets in general. This will help drive the push off the 80.00 support and begin the ascent to major resistance at 88.00 throughout the month of June. Target price for 07/03/2017: 90.00 Target price for 08/01/2017: 95.00 Target price for 09/01/2017: 105.00 These are my opinions only! Good luck!!
Top-line growth is the metric that makes Walgreens look good now. The company's revenue of $124 billion over a last 12 months is formidable, and the 12% spike in sales last quarter looks fantastic. Analysts believe that growth will continue and the company will reach $132 billion in sales in 2018.
A CEO who took over the company when stock was at an all time high. Then rode it like a cheap trick. Bringing it to an all time low. I know 30 year employees there who watched their retirement accounts disappearing as they neared retirement. Nobody shot him.
Just got a flu shot and picked up some meds. No. Not narcotics or VD. Chatted up the pharmacist about Village MD partnership. She compared it to selling beer at a gas station. Win Win.
The chart atop this thread seems to indicate the bottom may have been hit. Could be time to make a play. All aboard!
Prescription Business Picks Up at Walgreens -- Market Talk Today 8:38 AM ET (Dow Jones)Print 0838 ET - Walgreens says its prescriptions business in the US picked up in its fiscal 4Q. On a comparable basis, filled prescriptions rose 3.6% year over year, stronger than the scant 0.4% gain the company recorded on that metric for its 3Q. Overall pharmacy sales in the US, where Walgreens has most of its stores, rose 4.2%. Like other companies tied to health, Walgreens has faced challenges during the Covid-19 pandemic as some people skipped visiting doctors and avoided hospitals as they stayed largely at home while the virus spread. One question for the company is whether prescription demand may fall off again, with cases moving higher in many states. Walgreens shares rise 1.3% premarket. ([email protected]; @MicahMaidenberg) (END) Dow Jones Newswires October 15, 2020 08:38 ET (12:38 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.
